BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Védie A, Neuzillet C. Pancreatic cancer: Best supportive care. La Presse Médicale 2019;48:e175-85. [DOI: 10.1016/j.lpm.2019.02.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kryza T, Khan T, Puttick S, Li C, Sokolowski KA, Tse BW, Cuda T, Lyons N, Gough M, Yin J, Parkin A, Deryugina EI, Quigley JP, Law RHP, Whisstock JC, Riddell AD, Barbour AP, Wyld DK, Thomas PA, Rose S, Snell CE, Pajic M, He Y, Hooper JD. Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma. Theranostics 2020;10:4116-33. [PMID: 32226543 DOI: 10.7150/thno.43589] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
2 Turpin A, El Amrani M, Bachet JB, Pietrasz D, Schwarz L, Hammel P. Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021. Cancers (Basel) 2020;12:E3866. [PMID: 33371464 DOI: 10.3390/cancers12123866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
3 Jalal M, Campbell JA, Wadsley J, Hopper AD. Computed Tomographic Sarcopenia in Pancreatic Cancer: Further Utilization to Plan Patient Management. J Gastrointest Cancer 2021;52:1183-7. [PMID: 34292498 DOI: 10.1007/s12029-021-00672-4] [Reference Citation Analysis]
4 Thudium M, Bette B, Tonguc T, Ghaei S, Conrad R, Becher MU, Mücke M, Luechters G, Strunk H, Marinova M. Multidisciplinary management and outcome in pancreatic cancer patients treated with high-intensity focused ultrasound. Int J Hyperthermia 2020;37:456-62. [PMID: 32396479 DOI: 10.1080/02656736.2020.1762006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kasvis P, Kilgour RD. Diet and Exercise Interventions in Patients With Pancreatic Cancer: A Scoping Review. Pancreas 2021;50:657-66. [PMID: 34106574 DOI: 10.1097/MPA.0000000000001829] [Reference Citation Analysis]
6 Trestini I, Carbognin L, Peretti U, Sperduti I, Caldart A, Tregnago D, Avancini A, Auriemma A, Orsi G, Pilotto S, Frulloni L, Capurso G, Bria E, Reni M, Tortora G, Milella M. Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma. Front Oncol 2021;11:688889. [PMID: 34568019 DOI: 10.3389/fonc.2021.688889] [Reference Citation Analysis]
7 Hsueh HY, Pita-Grisanti V, Gumpper-Fedus K, Lahooti A, Chavez-Tomar M, Schadler K, Cruz-Monserrate Z. A review of physical activity in pancreatic ductal adenocarcinoma: Epidemiology, intervention, animal models, and clinical trials. Pancreatology 2021:S1424-3903(21)00607-4. [PMID: 34750076 DOI: 10.1016/j.pan.2021.10.004] [Reference Citation Analysis]